CoChat

Coagulase-negative staphylococci release a purine analog that inhibits Staphylococcus aureus virulence

Open access

The DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.

Abstract

Coagulase-negative staphylococci and Staphylococcus aureus colonize similar niches in mammals and conceivably compete for space and nutrients. Here, we report that a coagulase-negative staphylococcus, Staphylococcus chromogenes ATCC43764, synthesizes and secretes 6-thioguanine (6-TG), a purine analog that suppresses S. aureus growth by inhibiting de novo purine biosynthesis. We identify a 6-TG biosynthetic gene cluster in S. chromogenes and other coagulase-negative staphylococci including S. epidermidis, S. pseudintermedius and S. capitis. Recombinant S. aureus strains harbouring this operon produce 6-TG and, when used in subcutaneous co-infections in mice with virulent S. aureus USA300, protect the host from necrotic lesion formation. Used prophylactically, 6-TG reduces necrotic skin lesions in mice infected with USA300, and this effect is mediated by abrogation of toxin production. RNAseq analyses reveal that 6-TG downregulates expression of genes coding for purine biosynthesis, the accessory gene regulator (agr) and ribosomal proteins in S. aureus, providing an explanation for its effect on toxin production.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41467-021-22175-3

Cites

55 of 55 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 S. chromogenes secretes a molecule that inhibits S. aureus growth. a Simultaneous antagonism assay of selected representative CoNS on TSA. b S. aureus was cultured in TSB containing spent culture supernatant from S. chromogenes or S. aureus. The bacteria were grown for 24 h before they were plated and CFU/mL were enumerated. Results are pooled from three independent experiments. Data are shown as mean ± SD (n = 3, *p ≤ 0.05, ****p ≤ 0.0001. Two-sided unpaired t-test).
Fig. 1 S. chromogenes secretes a molecule that inhibits S. aureus growth. a Simultaneous antagonism assay of selected representative CoNS on TSA. b S. aureus was cultured in TSB containing spent culture supernatant from S. chromogenes or S. aureus. The bacteria were grown for 24 h before they were plated and CFU/mL were enumerated. Results are pooled from three independent experiments. Data are shown as mean ± SD (n = 3, *p ≤ 0.05, ****p ≤ 0.0001. Two-sided unpaired t-test).CC BY · PubMed Central
Fig. 2 Identification of a 6-TG biosynthetic gene cluster in S. chromogenes. a Molecular structure of 6-thioguanine. b E. amylovora ycf operon and S. chromogenes 6-TG biosynthetic operon. c Simultaneous antagonism assay using RN4220 pEmpty and ptgs on TSA. d S. aureus was cultured in TSB containing supernatant from RN4220 pEmpty or ptgs and plated 24 h.p.i and CFU/mL were enumerated. Results are pooled from two independent experiments, each with n = 3 replicates per condition. Data are shown as mean ± SD (**p ≤ 0.01. Two-sided unpaired t-test).
Fig. 2 Identification of a 6-TG biosynthetic gene cluster in S. chromogenes. a Molecular structure of 6-thioguanine. b E. amylovora ycf operon and S. chromogenes 6-TG biosynthetic operon. c Simultaneous antagonism assay using RN4220 pEmpty and ptgs on TSA. d S. aureus was cultured in TSB containing supernatant from RN4220 pEmpty or ptgs and plated 24 h.p.i and CFU/mL were enumerated. Results are pooled from two independent experiments, each with n = 3 replicates per condition. Data are shown as mean ± SD (**p ≤ 0.01. Two-sided unpaired t-test).CC BY · PubMed Central
Fig. 3 The tgs operon is present in other staphylococcal species and functional. a Phylogenetic analysis of the 6-TG operon using completed and draft Staphylococcus genomes. Black triangles represent a clade that was collapsed because their internal bootstrap values were <50%. SCa S. capitis, SCh S. chromogenes, SE S. epidermidis, SP S. pseudintermedius. b Simultaneous antagonism assay of tgs-negative and -positive staphylococcal strains on TSA. c Simultaneous antagonism assay using RN4220 pEmpty and pVCU116 tgs on TSA. d S. aureus was cultured in TSB containing supernatant from RN4220 pEmpty or pVCU116 tgs and plated 24 h.p.i and CFU/mL were enumerated. Results are pooled from two independent experiments, each with n = 3 replicates per condition. Data are shown as mean ± SD (**p ≤ 0.01. Two-sided unpaired t-test).
Fig. 3 The tgs operon is present in other staphylococcal species and functional. a Phylogenetic analysis of the 6-TG operon using completed and draft Staphylococcus genomes. Black triangles represent a clade that was collapsed because their internal bootstrap values were <50%. SCa S. capitis, SCh S. chromogenes, SE S. epidermidis, SP S. pseudintermedius. b Simultaneous antagonism assay of tgs-negative and -positive staphylococcal strains on TSA. c Simultaneous antagonism assay using RN4220 pEmpty and pVCU116 tgs on TSA. d S. aureus was cultured in TSB containing supernatant from RN4220 pEmpty or pVCU116 tgs and plated 24 h.p.i and CFU/mL were enumerated. Results are pooled from two independent experiments, each with n = 3 replicates per condition. Data are shown as mean ± SD (**p ≤ 0.01. Two-sided unpaired t-test).CC BY · PubMed Central
Fig. 4 tgs expressing staphylococci reduce skin damage caused by S. aureus during co-infection. a Representative images showing necrotic skin lesions 4 days post infection with S. aureus + tgs-negative S. epidermidis str. VCU036 or S. aureus + tgs-positive S. epidermidis str. M23864:W2 in a 1:1 ratio. b Quantitation of necrotic skin lesion size 4 days post infection with S. aureus + tgs-negative S. epidermidis str. VCU036 or S. aureus + tgs-positive S. epidermidis str. M23864:W2 in a 1:1 ratio. Results are from one representative experiment enumerating 8 lesions per group (n = 4 animals per group). Data are shown as mean ± SD (***p ≤ 0.001. Two-sided unpaired t-test). c Representative images showing necrotic skin lesions 4 days post infection with S. aureus + RN4220 pEmpty or S. aureus + RN4220 ptgs in a 1:1 ratio. d Quantitation of necrotic skin lesion size 4 days post infection with S. aureus + RN4220 pEmpty or S. aureus + RN4220 ptgs in a 1:1 ratio. Results are from one experiment enumerating 8 lesions per group (n = 4 animals per group). Data are shown as mean ± SD (***p ≤ 0.001. Two-sided unpaired t-test).
Fig. 4 tgs expressing staphylococci reduce skin damage caused by S. aureus during co-infection. a Representative images showing necrotic skin lesions 4 days post infection with S. aureus + tgs-negative S. epidermidis str. VCU036 or S. aureus + tgs-positive S. epidermidis str. M23864:W2 in a 1:1 ratio. b Quantitation of necrotic skin lesion size 4 days post infection with S. aureus + tgs-negative S. epidermidis str. VCU036 or S. aureus + tgs-positive S. epidermidis str. M23864:W2 in a 1:1 ratio. Results are from one representative experiment enumerating 8 lesions per group (n = 4 animals per group). Data are shown as mean ± SD (***p ≤ 0.001. Two-sided unpaired t-test). c Representative images showing necrotic skin lesions 4 days post infection with S. aureus + RN4220 pEmpty or S. aureus + RN4220 ptgs in a 1:1 ratio. d Quantitation of necrotic skin lesion size 4 days post infection with S. aureus + RN4220 pEmpty or S. aureus + RN4220 ptgs in a 1:1 ratio. Results are from one experiment enumerating 8 lesions per group (n = 4 animals per group). Data are shown as mean ± SD (***p ≤ 0.001. Two-sided unpaired t-test).CC BY · PubMed Central
Fig. 5 Prophylactic treatment with 6-TG reduces necrotic lesion size in subcutaneous infection. a Representative images showing necrotic skin lesions 4 days post infection with S. aureus ± prophylactic 6-TG treatment. b Quantitation of necrotic skin lesion size 4 days post infection with S. aureus ± prophylactic 6-TG (20 µg) treatment. Results are pooled from two independent experiments with 8–12 lesions per group (n = 4 and 6 animals, respectively). Data are shown as mean ± SD (****p ≤ 0.0001. Two-sided unpaired t-test). c Skin tissue was excised from mice infected with S. aureus 4 days post infection ± prophylactic 6-TG treatment (20 µg) and plated onto TSA to enumerate CFUs. Results are from one experiment with 8–12 lesions per group (n = 4 and 6 animals, respectively). Data are shown as mean ± SD (two-sided unpaired t-test).
Fig. 5 Prophylactic treatment with 6-TG reduces necrotic lesion size in subcutaneous infection. a Representative images showing necrotic skin lesions 4 days post infection with S. aureus ± prophylactic 6-TG treatment. b Quantitation of necrotic skin lesion size 4 days post infection with S. aureus ± prophylactic 6-TG (20 µg) treatment. Results are pooled from two independent experiments with 8–12 lesions per group (n = 4 and 6 animals, respectively). Data are shown as mean ± SD (****p ≤ 0.0001. Two-sided unpaired t-test). c Skin tissue was excised from mice infected with S. aureus 4 days post infection ± prophylactic 6-TG treatment (20 µg) and plated onto TSA to enumerate CFUs. Results are from one experiment with 8–12 lesions per group (n = 4 and 6 animals, respectively). Data are shown as mean ± SD (two-sided unpaired t-test).CC BY · PubMed Central
Fig. 6 6-TG reduces S. aureus toxin production in a purine-dependent and -independent manner. a S. aureus was grown in the presence of 6-TG (10 µg/mL) or a vehicle control to an OD600 of 7.0 and secreted proteins in the supernatant were TCA precipitated and separated by SDS-PAGE. This experiment was repeated three times with similar results. b Protein samples in a were immunoblotted and probed with anti-alpha toxin antibody in a Western blot. Protein identification was by MALDI TOF MS. Numbers indicate molecular mass markers. This experiment was repeated three times with similar results. c S. aureus and S. aureus purK::ΦΝΣ was grown in TSB with 6-TG (10 µg/mL) or a vehicle control to an OD600 of 7.0 and secreted proteins in the supernatant were TCA precipitated and separated by SDS-PAGE. This experiment was repeated twice with similar results. d Protein samples in c were immunoblotted and probed with anti-alpha toxin antibody in a Western blot. This experiment was repeated twice with similar results. e Quantitation of necrotic skin lesion size 4 days post infection with S. aureus or S. aureus purK::ΦΝΣ ± prophylactic 6-TG (20 µg) treatment. Results are from one representative experiment with 16 lesions enumerated per group (n = 8 animals). Data are shown as mean ± SD (***p ≤ 0.001, **p ≤ 0.01, *p ≤ 0.05. Two-sided unpaired t-test). f Skin tissue was excised from mice infected with S. aureus or S. aureus purK::ΦΝΣ 4 days post infection ± prophylactic 6-TG (20 µg) treatment and plated onto TSA to enumerate CFUs. Results are from one representative experiment with 16 lesions enumerated per group (n = 8 animals). Data are shown as mean ± SD (***p ≤ 0.001. Two-sided unpaired t-test). For a–d, numbers to the left of gels/blots are molecular mass markers (in kDa).
Fig. 6 6-TG reduces S. aureus toxin production in a purine-dependent and -independent manner. a S. aureus was grown in the presence of 6-TG (10 µg/mL) or a vehicle control to an OD600 of 7.0 and secreted proteins in the supernatant were TCA precipitated and separated by SDS-PAGE. This experiment was repeated three times with similar results. b Protein samples in a were immunoblotted and probed with anti-alpha toxin antibody in a Western blot. Protein identification was by MALDI TOF MS. Numbers indicate molecular mass markers. This experiment was repeated three times with similar results. c S. aureus and S. aureus purK::ΦΝΣ was grown in TSB with 6-TG (10 µg/mL) or a vehicle control to an OD600 of 7.0 and secreted proteins in the supernatant were TCA precipitated and separated by SDS-PAGE. This experiment was repeated twice with similar results. d Protein samples in c were immunoblotted and probed with anti-alpha toxin antibody in a Western blot. This experiment was repeated twice with similar results. e Quantitation of necrotic skin lesion size 4 days post infection with S. aureus or S. aureus purK::ΦΝΣ ± prophylactic 6-TG (20 µg) treatment. Results are from one representative experiment with 16 lesions enumerated per group (n = 8 animals). Data are shown as mean ± SD (***p ≤ 0.001, **p ≤ 0.01, *p ≤ 0.05. Two-sided unpaired t-test). f Skin tissue was excised from mice infected with S. aureus or S. aureus purK::ΦΝΣ 4 days post infection ± prophylactic 6-TG (20 µg) treatment and plated onto TSA to enumerate CFUs. Results are from one representative experiment with 16 lesions enumerated per group (n = 8 animals). Data are shown as mean ± SD (***p ≤ 0.001. Two-sided unpaired t-test). For a–d, numbers to the left of gels/blots are molecular mass markers (in kDa).CC BY · PubMed Central
Fig. 7 6-TG abrogates toxin production by reducing transcription from the agr locus and from genes encoding for ribosomal proteins. a RNA-seq analysis of wild-type S. aureus cultures treated with a vehicle control or 6-TG (10 µg/mL) in TSB. Data points above the dashed lines along the x-axis represent p ≤ 0.01. Data points outside of the dashed lines along the y-axis represent fold changes of ≥2.0. Results are from four independent experiments. b RNA-seq analysis of S. aureus purK::ΦΝΣ cultures treated with a vehicle control compared to wild-type S. aureus cultures treated with a vehicle control in TSB. Results are from four independent experiments. c RNA-seq analysis of S. aureus purK::ΦΝΣ cultures treated with a vehicle control or 6-TG (10 µg/mL) in TSB. Results are from four independent experiments. d RNA-seq analysis of wild-type S. aureus cultures and S. aureus purK::ΦΝΣ cultures treated with 6-TG (10 µg/mL) in TSB. Results are from four independent experiments. Statistical significance was determined using a negative binomial distribution. Detailed RNA-seq data can be found in Supplementary Data 2.
Fig. 7 6-TG abrogates toxin production by reducing transcription from the agr locus and from genes encoding for ribosomal proteins. a RNA-seq analysis of wild-type S. aureus cultures treated with a vehicle control or 6-TG (10 µg/mL) in TSB. Data points above the dashed lines along the x-axis represent p ≤ 0.01. Data points outside of the dashed lines along the y-axis represent fold changes of ≥2.0. Results are from four independent experiments. b RNA-seq analysis of S. aureus purK::ΦΝΣ cultures treated with a vehicle control compared to wild-type S. aureus cultures treated with a vehicle control in TSB. Results are from four independent experiments. c RNA-seq analysis of S. aureus purK::ΦΝΣ cultures treated with a vehicle control or 6-TG (10 µg/mL) in TSB. Results are from four independent experiments. d RNA-seq analysis of wild-type S. aureus cultures and S. aureus purK::ΦΝΣ cultures treated with 6-TG (10 µg/mL) in TSB. Results are from four independent experiments. Statistical significance was determined using a negative binomial distribution. Detailed RNA-seq data can be found in Supplementary Data 2.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 55 references

Cited by

See all 72

Metadata

Authors
Chin, D., Goncheva, M. I., Flannagan, R. S., Deecker, S. R., Guariglia-Oropeza, V., Ensminger, A. W., & Heinrichs, D. E.
Affiliations
  • Western University (CA)
  • MaRS (CA)
Corresponding author
Heinrichs, David E.
Venue
Nature Communications
Published
2021-03-25
Volume
12
Issue
1
Pages
1887-1887
ISSN
2041-1723 (ISSN-L)
OpenAlex
W3138233583
Cited by
72
References
55
Citations by year
2026: 8 · 2025: 23 · 2024: 17 · 2023: 6 · 2022: 14 · 2021: 4
FWCI
3.24
Type
journal article
Language
en
Open access
Licence
Locations
  • Nature Communications (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
Gouvernement du Canada | Canadian Institutes of Health Research (PJT-153308)
Topics
  • Health Sciences › Medicine › Infectious Diseases › Antimicrobial Resistance in Staphylococcus
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bacterial biofilms and quorum sensing
  • Life Sciences › Immunology and Microbiology › Applied Microbiology and Biotechnology › Microbial Natural Products and Biosynthesis
Keywords
coagulase-negative staphylococci, Staphylococcus aureus, 6-thioguanine, purine analogues, purine biosynthesis inhibition, bacterial competition, Staphylococcus chromogenes, Staphylococcus epidermidis, Staphylococcus pseudintermedius, Staphylococcus capitis, USA300, necrotic skin lesions, toxin production, accessory gene regulator, bacterial co-infection, prophylaxis
MeSH terms
Staphylococcus capitis, Animals, Bacterial Proteins, Coagulase, Female, Mice, Inbred BALB C, Purines, Ribosomal Proteins, Staphylococcal Skin Infections, Staphylococcus, Staphylococcus aureus, Staphylococcus epidermidis, Thioguanine, Trans-Activators, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Coagulase-negative staphylococci release a purine analog that inhibits Staphylococcus aureus virulence. https://app.cochat.ai/papers/10.1038/s41467-021-22175-3
The paper
Chin, D., Goncheva, M. I., Flannagan, R. S., Deecker, S. R., Guariglia-Oropeza, V., Ensminger, A. W., & Heinrichs, D. E. (2021). Coagulase-negative staphylococci release a purine analog that inhibits Staphylococcus aureus virulence. Nature Communications. https://doi.org/10.1038/s41467-021-22175-3

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.